Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil (Q34421898)

2 August 2017

title

Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil (English)

1 reference

2 August 2017

0 references

Charles Duyckaerts

1 reference

2 August 2017

Mathieu Gaudin

1 reference

2 August 2017

Maï Panchal

1 reference

2 August 2017

Nicolas Auzeil

1 reference

2 August 2017

Alain Brunelle

1 reference

2 August 2017

Olivier Laprévote

1 reference

2 August 2017

David Touboul

1 reference

2 August 2017

publication date

1 September 2012

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

2153-5159

1 reference

Classification and basic pathology of Alzheimer disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Serum sphingomyelins and ceramides are early predictors of memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Brain membrane phospholipid alterations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Electrospray mass spectrometry of phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Comprehensive LC-MS E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Brain lipid concentrations in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Altered membrane lipid composition in a human meningosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Evidence for a membrane defect in Alzheimer disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Linking lipids to Alzheimer's disease: cholesterol and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Regulation and inhibition of phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Phospholipase D in brain function and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.189

21 January 2018

Identifiers

DOI

10.4155/BIO.12.189

0 references

1 reference